These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 28848211

  • 1. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis.
    An N, Shi Y, Ye P, Pan Z, Long X.
    Cell Physiol Biochem; 2017; 42(6):2430-2440. PubMed ID: 28848211
    [Abstract] [Full Text] [Related]

  • 2. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A, Ahmad ST, Malik AA, Aziz SA, Rasool Z, Masood A, Zargar MA.
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
    Yuan X, Xu J, Fang W, Zhao Z, Wang F, Tong Z.
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
    [Abstract] [Full Text] [Related]

  • 5. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigation of promoter methylation patterns association with genes expression profile of ISL1, MGMT and DMNT3b in tissue of breast cancer patients.
    Yari H, Shabani S, Nafissi N, Majidzadeh T, Mahjoubi F.
    Mol Biol Rep; 2022 Feb; 49(2):847-857. PubMed ID: 34997427
    [Abstract] [Full Text] [Related]

  • 9. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
    Spitzwieser M, Holzweber E, Pfeiler G, Hacker S, Cichna-Markl M.
    Breast Cancer Res; 2015 Sep 14; 17(1):125. PubMed ID: 26370119
    [Abstract] [Full Text] [Related]

  • 10. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
    Zhao H, Wang S, Song C, Zha Y, Li L.
    World J Surg Oncol; 2016 Oct 12; 14(1):261. PubMed ID: 27733166
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, Lai A.
    Neuro Oncol; 2017 Mar 01; 19(3):394-404. PubMed ID: 27571882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.
    Li CC, Yu Z, Cui LH, Piao JM, Liu M.
    Asian Pac J Cancer Prev; 2014 Mar 01; 15(16):6591-6. PubMed ID: 25169493
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.